ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Seffrin, Thomas Lead List of ACS Exec. VP Candidates, Reportedly

May 1, 1992

All 59 CCOP Awards Announced Heavy In Northeast, Fair In Midwest; Amounts, Priority Scores Listed

June 3, 1983

Avon Awards $30M To 13 Organizations

September 27, 2002

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Reponses To Ford’s Request For Scientific Rational Of Cigarette Regulation Based On Epidemiologic Studies

November 8, 1974

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002